MSLN and familial pancreatic carcinoma: For instance, Chimeric Antigen Receptor (CAR) T cells engineered to target a native protein mesothelin overexpressed on pancreatic cancer cells show significant anti-tumor activity independent of chemotherapy or radiation [124].